Li C, Klingler S, Bodo S, Cheng J, Pan Y, Adileh M, Martin MLaura, Fuller J, Feldman R, Michel A et al..
2022.
Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate.. Cell Physiol Biochem. 56(4):436-448.
Jaiswal A, Verma A, Dannenfelser R, Melssen M, Tirosh I, Izar B, Kim T-G, Nirschl CJ, K Devi SP, Olson WC et al..
2022.
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.. Cancer Cell. 40(5):524-544.e5.
Orlando F, Romanel A, Trujillo B, Sigouros M, Wetterskog D, Quaini O, Leone G, Xiang JZ, Wingate A, Tagawa S et al..
2022.
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.. NAR Cancer. 4(2):zcac016.
Ciani Y, Fedrizzi T, Prandi D, Lorenzin F, Locallo A, Gasperini P, Franceschini GMarco, Benelli M, Elemento O, Fava LL et al..
2022.
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.. Cell Syst. 13(2):183-193.e7.
Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, Botta GP, Catenacci DVT, Maron SB, Krinshpun S et al..
2022.
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.. JCO Precis Oncol. 6:e2200420.
Meggendorfer M, Jobanputra V, Wrzeszczynski KO, Roepman P, de Bruijn E, Cuppen E, Buttner R, Caldas C, Grimmond S, Mullighan CG et al..
2022.
Analytical demands to use whole-genome sequencing in precision oncology.. Semin Cancer Biol. 84:16-22.
Brendel M, Su C, Bai Z, Zhang H, Elemento O, Wang F.
2022.
Application of Deep Learning on Single-cell RNA Sequencing Data Analysis: A Review.. Genomics Proteomics Bioinformatics. 20(5):814-835.
Elkhader J, Elemento O.
2022.
Artificial intelligence in oncology: From bench to clinic.. Semin Cancer Biol. 84:113-128.
Fucikova J, Hensler M, Kasikova L, Lanickova T, Pasulka J, Rakova J, Drozenova J, Fredriksen T, Hraska M, Hrnciarova T et al..
2022.
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.. Clin Cancer Res. 28(14):3053-3065.